October 19, 2025

ADC Improves Outcomes for Patients with Advanced Triple-Negative Breast Cancer Who are Ineligible for Immune Checkpoint Inhibitors

Patients with an aggressive form of breast cancer who are not candidates for immune checkpoint inhibitor therapy showed significantly improved progression-free survival when treated with the antibody drug conjugate sacituzumab govitecan compared to standard chemotherapy.

Dana-Farber

October 14, 2025

Do Quadruple Therapies Beat Triple for H. pylori?

Concomitant and bismuth quadruple regimens cleared ~90% of patients and outperformed triple therapy; sequential achieved ~84%. Adherence remained ~97% despite higher but manageable side effects.

Conexiant

October 14, 2025

What Happened at Meeting on the Mesa 2025?

This year’s Meeting on the Mesa showed that cell and gene therapy is no longer defined by hype, but by hard work– from digital manufacturing to creative funding models and policy alignment.

The Medicine Maker

October 13, 2025

Join Roswell Park Revolutionaries for Cell Therapy Symposium at ASH

Renier Brentjens, MD, PhD, and Marco Davila, MD, PhD, will host a satellite symposium during this year’s ASH meeting to discuss the evolving landscape of CAR T-cell therapy.

Roswell Park Comprehensive Cancer Center

October 13, 2025

Breast, Lung, and Bladder Cancer Phase 3 Trials led by Dana-Farber Presented at ESMO Congress 2025

Dana-Farber Cancer Institute researchers are leading four studies with important new findings in breast cancer, lung cancer, and bladder cancer at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany.

Dana-Farber

October 08, 2025

Use of Obecabtagene Autoleucel CAR T-Cell Therapy for B-Cell Acute Lymphocytic Leukemia

Treatment with obecabtagene autoleucel was the focus of the phase Ib/II multicenter FELIX study of more than 100 adults with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL).1 The init...

The ASCO Post

October 07, 2025

Global IBD Trial Experts Agree on Steroid Standards

Global inflammatory bowel disease experts issued new guidance on how steroids should be managed in clinical trial settings.

Conexiant

October 07, 2025

Open Versus Robotic Liver Resections, Study Results

Complication rates and hospital stays were analyzed across both surgical groups.

Conexiant

October 03, 2025

Fruit Intake: Does It Alter PM2.5 Effect?

UK Biobank analysis examines diet quality and fruit intake in relation to PM2.5 lung effects.

Conexiant